Aegis Digital Health
What is Aegis Digital Health, DBA SweetSpot?
Aegis’ first product, SweetSpot, is a software platform and clinical support service that supports end-to-end remote patient monitoring for all diabetes devices.
Company Leadership
Stephen Von Rump
Co-Founder & CEO
Stephen Von Rump, MS, is a 5-time CEO and 3-time founder with 3 exits. He has extensive healthcare sales and operational experience, and has developed, launched and managed a dozen products in the healthcare technology space.
Connect on LinkedInRalph Oiknine, MD
Co-Founder & Chief Medical Officer
Ralph Oiknine, MD, is an endocrinologist with over 20 years of clinical experience, and is nationally known among diabetes clinicians and industry leaders. He is the inventor of the SweetSpot concept, born out of years of frustration with the existing standard of care for diabetes patients.
Connect on LinkedInAmiad Fredman, MD
Co-Founder & Chief Product Officer
Amiad Fredman, MD, is nationally known digital health thought leader with experience driving product development. His focus is on maximizing user engagement, and he brings both clinical and design expertise to the task.
Connect on LinkedInAbby Cohen
Co-Chief Executive Officer
Abby Cohen, BME, was the founder and CEO of Sparo, which had an exit in 2022. She has extensive product development and operations experience, FDA regulatory and quality experience, early partner development and revenue generation experience. Abby earned her degree in Biomedical/Medical Engineering from Washington University in St. Louis in 2013, and brings experience working with Barnes Jewish Hospital to her position with Sparo.
Connect on LinkedInKay Broschat, PhD
Co-Founder & Principal Investigator
Kay Bouschat is a seasoned project management professional with a substantial 30-year track record that spans academia, startups, and pharmaceutical companies. She has demonstrated a robust ability to secure funding for research and development through diverse channels including NIH grants, venture capital, pharmaceutical partnerships, and strategic alliances. Specializing in pharmaceuticals, medical devices, and diagnostic translational medicine, Kay has been pivotal in recruiting and fostering the adoption of new medical practices among Key Opinion Leaders. Her strategic insight into in-licensing and alliance structures has proven invaluable for therapeutics and technology transfer, underscoring her role as a dynamic force in the advancement of medical innovation and enterprise.
Connect on LinkedIn